{"name":"Glycovax Pharma Inc.","slug":"glycovax-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOVExKQk5tQTJDRUducWhULUpob2ppVzdVejBoMTRoSGlVeEFNN1diWWZMRWkzM1NEQWdna2xWNDZDTlVJTkJUTzI0NHFNOWdkS3BrWjVQSElZMmF0OFZNM0RWU0FNaWhWdTBnY3k1LVJ6dS1TaF9fTlZDNkdqZXdoTW05X1R6c2NDdWN6QlZDb010YXZFM2s4dVkxcGRIZ0VmZk1RUzVWRjM4TWZnWUV3MzI1TzhnOGRMNkw4NmZB?oc=5","date":"2025-10-09","type":"deal","source":"Contract Pharma","summary":"Glycovax Pharma, NRC, Montréal U, Partner to Develop Vax Against Pa Infections - Contract Pharma","headline":"Glycovax Pharma, NRC, Montréal U, Partner to Develop Vax Against Pa Infections","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-08","type":"pipeline","source":"PR Newswire","summary":"Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible t","headline":"Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innov","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}